NCT06669650
Personalized Post-Operative Pain Management
StatusUnknown
PhasePhase 4
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Active, Not Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Persistent Post-Operative Opioid Use
Timeframe: 90 days
Secondary (1)
Post-Surgical Pain
Arms and interventions
Standard post-operative pain management (control)Active comparator
Patients in the control groups will follow the current hospital standard of care and receive oxycodone 5mg every 4 hours as needed for moderate pain and oxycodone 10mg every four hours as needed for severe pain.
Pharmacogenomics (PGx) guided treatment (hydromorphone)Experimental
Patients who are poor CYP2D6 metabolizers or rapid CYP2D6 metabolizers with moderate or severe pain, will be prescribed either oral hydromorphone 2mg every 4 hours as needed or oral hydromorphone 4mg every 4 hours as needed, respectively.
Other: PGx guided personalized post-operative pain management
Drugs: Oxycodone, Hydromorphone
Sites
1 site in 1 country
- The University of Tennessee Graduate School of MedicineKnoxville, Tennessee, United States